Showing results (181-190 of 189) with videos related to
Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Tuberculosis and Respiratory Diseases|October 20, 2021
A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in KoreaHyun Woo Lee, Yun Su Sim, Ji Ye Jung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trialGeorge R Blumenschein, Pierre Saintigny, Suyu Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Solid Tumors: Primary Analysis of All Tumor-Histology Baskets of the Phase II Randomized EXTEND TrialAlexander D Sherry, Cara Haymaker, Shuqi Wang, et al.The Lancet. Oncology|September 7, 2025
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trialChad Tang, Alexander D Sherry, Aaron Seo, et al.Cancer Discovery|April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockadeXianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2024
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II TrialEthan B Ludmir, Alexander D Sherry, Bryan M Fellman, et al.European Urology|August 1, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND TrialAlexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.Cancer Discovery|July 15, 2021
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal MesotheliomaKanwal Raghav, Suyu Liu, Michael J Overman, et al.Cancer Letters|May 7, 2026
Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progressionChandra Sekhar Amara, Danthasinghe Waduge Badrajee Piyarathna, Abu Hena Mostafa Kamal, et al.Pageof 19